<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05079932</url>
  </required_header>
  <id_info>
    <org_study_id>612_2021</org_study_id>
    <nct_id>NCT05079932</nct_id>
  </id_info>
  <brief_title>Pilot Study for the Evaluation of Food Choices in Patients With Inflammatory Bowel Diseases (MICI2021)</brief_title>
  <acronym>MICI2021</acronym>
  <official_title>Pilot Study for the Evaluation of Food Choices and Exclusion of Gluten From the Diet in Patients With Inflammatory Bowel Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project is a pilot study exploring the effects of dietary choices and quantitative&#xD;
      digestion of gluten ingested by individuals with IBD compared to a control population. The&#xD;
      aim of the study is to evaluate for the first time in an Italian population of subjects with&#xD;
      IBD the presence of a diet based on GFD (gluten free diet).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects with IBD will be recruited among the patients referred to the IBD clinic of the&#xD;
      Policlinico of Milan. These patients are subject to annual check-ups during which, where&#xD;
      possible, they will be asked to sign an informed consent. These patients are subjected during&#xD;
      the visits of normal clinical follow-up to:&#xD;
&#xD;
        -  Questionnaire on eating habits for the patient with IBD versus control patients;&#xD;
&#xD;
        -  Modified Food Habits Frequency Questionnaire (FFQ), validated for the celiac population.&#xD;
           The questionnaire assesses the extent, frequencies of consumption and quantity of&#xD;
           gluten-containing foods in a year; this, in order to estimate the average introduction&#xD;
           of gluten through the diet versus control patients;&#xD;
&#xD;
        -  Anthropometric and plicometric analysis;&#xD;
&#xD;
        -  Validated clinical activity questionnaires for RCU (ulcerative rectocolitis) and CD&#xD;
           (Chron disease) (Mayo Score and Harvey-Bradshaw Index).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dietary habits in IBD patients</measure>
    <time_frame>April 2021- April 2023</time_frame>
    <description>Quantification of gluten intake by IBD patients compared with the control population.&#xD;
Evaluation of foods excluded from the diet of IBD patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of weight</measure>
    <time_frame>April 2021- April 2023</time_frame>
    <description>Assessment of weight (kilograms) in IBD patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of height</measure>
    <time_frame>April 2021- April 2023</time_frame>
    <description>Assessment of height (meters) in IBD patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of clinical disease activity</measure>
    <time_frame>April 2021- April 2023</time_frame>
    <description>Evaluation of validated clinical activity indices for RCU in IBD patients (Mayo Score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of clinical disease activity</measure>
    <time_frame>April 2021- April 2023</time_frame>
    <description>Evaluation of validated clinical activity indices for CD in IBD patients (Harvey-Bradshaw Index)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Inflammatory Bowel Diseases</condition>
  <eligibility>
    <study_pop>
      <textblock>
        30 patients with IBD (15 CD and 15 RCU) and 15 patients from the control population&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 18 years&#xD;
&#xD;
          -  Gender: women and men&#xD;
&#xD;
          -  Patients who have been diagnosed with IBD for at least 12 months&#xD;
&#xD;
          -  patients who have signed an informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy status&#xD;
&#xD;
          -  Patients not suffering from the two main forms of IBD, i.e. CD or RCU (unclassified&#xD;
             IBD colitis, collagenous colitis, lymphocytic colitis will be excluded).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luca Elli, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maurizio Vecchi, doctor</last_name>
    <phone>0255033418</phone>
    <email>maurizio.vecchi@policlinico.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Weaver KN, Herfarth H. Gluten-Free Diet in IBD: Time for a Recommendation? Mol Nutr Food Res. 2021 Mar;65(5):e1901274. doi: 10.1002/mnfr.201901274. Epub 2020 Jun 28. Review.</citation>
    <PMID>32558265</PMID>
  </results_reference>
  <results_reference>
    <citation>Mazzeo T, Roncoroni L, Lombardo V, Tomba C, Elli L, Sieri S, Grioni S, Bardella MT, Agostoni C, Doneda L, Brighenti F, Pellegrini N. Evaluation of a Modified Italian European Prospective Investigation into Cancer and Nutrition Food Frequency Questionnaire for Individuals with Celiac Disease. J Acad Nutr Diet. 2016 Nov;116(11):1810-1816. doi: 10.1016/j.jand.2016.04.013. Epub 2016 May 28.</citation>
    <PMID>27245762</PMID>
  </results_reference>
  <results_reference>
    <citation>Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987 Dec 24;317(26):1625-9.</citation>
    <PMID>3317057</PMID>
  </results_reference>
  <results_reference>
    <citation>Dhanda AD, Creed TJ, Greenwood R, Sands BE, Probert CS. Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials? Inflamm Bowel Dis. 2012 Nov;18(11):2056-62. doi: 10.1002/ibd.22879. Epub 2012 Jan 23.</citation>
    <PMID>22271464</PMID>
  </results_reference>
  <results_reference>
    <citation>Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980 Mar 8;1(8167):514.</citation>
    <PMID>6102236</PMID>
  </results_reference>
  <results_reference>
    <citation>Elli L, Bascuñán K, di Lernia L, Bardella MT, Doneda L, Soldati L, Orlando S, Ferretti F, Lombardo V, Barigelletti G, Scricciolo A, Fabiano S, Vecchi M, Roncoroni L. Safety of occasional ingestion of gluten in patients with celiac disease: a real-life study. BMC Med. 2020 Mar 16;18(1):42. doi: 10.1186/s12916-020-1511-6.</citation>
    <PMID>32172690</PMID>
  </results_reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 23, 2021</study_first_submitted>
  <study_first_submitted_qc>October 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2021</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</investigator_affiliation>
    <investigator_full_name>Luca Elli, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Ulcerative rectocolitis</keyword>
  <keyword>Crohn Disease</keyword>
  <keyword>Gluten-free diet</keyword>
  <keyword>IBD</keyword>
  <keyword>Nutrition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

